Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 5, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Deciphering squamous cell carcinoma using multidimensional genomic approaches.

Ewan A Gibb1, Katey S S Enfield, Ivy F L Tsui

  • 1Department of Integrative Oncology, British Columbia Cancer Agency Research Centre, Vancouver BC, Canada V5Z 1L3.

Journal of Skin Cancer
|January 15, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Large distant deletion disrupts CDKN2A enhancer and predisposes to melanoma.

medRxiv : the preprint server for health sciences·2026
Same author

Disruption of CTCF binding by germline non-coding variants in <i>CDKN2B</i> suppress <i>CDKN2A</i> expression and predispose to melanoma.

medRxiv : the preprint server for health sciences·2026
Same author

DNA repair drives cisplatin-induced neuronal death.

Cell·2026
Same author

Gene amplification in the premalignant stages of non-small cell lung cancer development.

Frontiers in oncology·2026
Same author

Pervasive Cas9 expression driven by mammalian promoter activity in E. coli affects representation of CRISPR sgRNA libraries.

Communications biology·2026
Same author

Functional characterization of the 9q34.13 locus identifies <i>RAPGEF1</i> as modulating risk for melanoma and nevi via RAS activation.

bioRxiv : the preprint server for biology·2026
Same journal

Five-Year Follow-Up of Patients With Histologically Aggressive Basal Cell Carcinoma Treated With Interferon.

Journal of skin cancer·2026
Same journal

Cutaneous Lymphomas and Lymphoproliferative Disorders Associated With SARS-CoV-2 Vaccination: A Systematic Review.

Journal of skin cancer·2026
Same journal

Clinical Outcomes of Sonidegib in Vismodegib-Exposed Locally Advanced Basal Cell Carcinoma: Insights From a Multicenter Descriptive Study.

Journal of skin cancer·2026
Same journal

Prevalence and Severity of Sleep Disorders in Patients With Mycosis Fungoides: A Case-Control Study.

Journal of skin cancer·2026
Same journal

Prognostic Potential of Baseline Eosinophils at the Initiation of Immune Checkpoint Inhibitor Treatment of Metastatic Melanoma: A Systematic Review and Meta-Analysis.

Journal of skin cancer·2025
Same journal

Phytochemicals From <i>Houttuynia cordata</i> Thunb as Potential Inhibitors of BRAF, MEK, and ERK: Insights From Molecular Docking.

Journal of skin cancer·2025
See all related articles

Squamous cell carcinomas (SqCCs) are diverse cancers. Integrative genomics advances the study of SqCC genetics, revealing crucial similarities and differences across various tissue origins for better understanding.

Area of Science:

  • Genomics
  • Oncology
  • Molecular Biology

Background:

  • Squamous cell carcinomas (SqCCs) originate from epithelial cells in diverse tissues like skin, lung, and oral mucosa.
  • Despite a shared nomenclature, SqCCs exhibit significant variations in incidence, prognosis, and treatment strategies.
  • Existing knowledge on genetic commonalities and distinctions among SqCCs is inadequate for a comprehensive biological understanding.

Purpose of the Study:

  • To provide an overview of whole genome approaches for gene and pathway discovery in SqCCs.
  • To highlight the role of integrative genomics in advancing the study of SqCC genetics.
  • To improve the understanding of the biological basis of SqCCs from diverse tissue origins.

Main Methods:

  • Review of whole genome sequencing and analysis techniques.

More Related Videos

Isolation of Cells with Morphological and Spatial Information from Oral Submucous Fibrosis Samples by Laser Capture Microdissection
05:42

Isolation of Cells with Morphological and Spatial Information from Oral Submucous Fibrosis Samples by Laser Capture Microdissection

Published on: August 11, 2023

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Experiment Videos

Last Updated: Jun 5, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Isolation of Cells with Morphological and Spatial Information from Oral Submucous Fibrosis Samples by Laser Capture Microdissection
05:42

Isolation of Cells with Morphological and Spatial Information from Oral Submucous Fibrosis Samples by Laser Capture Microdissection

Published on: August 11, 2023

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

  • Exploration of gene and pathway discovery methodologies.
  • Emphasis on the application of integrative genomics strategies.

    • Main Results:

    • Whole genome approaches offer powerful tools for identifying genetic alterations in SqCCs.
    • Integrative genomics enables the combination of diverse datasets for a holistic view of SqCC genetics.
    • Advancements in these methods are crucial for dissecting the heterogeneity of SqCCs.

    Conclusions:

    • Understanding the genetic landscape of SqCCs is essential for improving patient outcomes.
    • Integrative genomics represents a state-of-the-art technology for SqCC research.
    • Further application of these genomic strategies will elucidate the biology of SqCCs across different tissues.